Immunotherapeutic perspective for bispecific antibodies
- 1 August 2000
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 21 (8) , 391-397
- https://doi.org/10.1016/s0167-5699(00)01659-5
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Novel tetravalent and bispecific IgG‐like antibody molecules combining single‐chain diabodies with the immunoglobulin γ1 Fc or CH3 regionFEBS Letters, 1999
- Effective Phagocytosis and Killing ofCandida albicansvia Targeting FcγRI (CD64) or FcαRI (CD89) on NeutrophilsThe Journal of Infectious Diseases, 1999
- An efficient route to human bispecific IgGNature Biotechnology, 1998
- Design and production of novel tetravalent bispecific antibodiesNature Biotechnology, 1997
- Mix and match: Building manifold binding sitesNature Biotechnology, 1997
- Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice.Journal of Clinical Investigation, 1996
- Regression of Advanced Ovarian Carcinoma by Intraperitoneal Treatment With Autologous TLymphocytes Retargeted by a Bispecific Monoclonal AntibodyJNCI Journal of the National Cancer Institute, 1995
- Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphomaNature, 1993
- Preliminary trial of specific targeting therapy against malignant gliomaThe Lancet, 1990
- Immune adherence and the processing of soluble complement-fixing antibody/DNA immune complexes in miceClinical Immunology and Immunopathology, 1989